By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Matinas BioPharma 

915 Klosterman Road East

Tarpon Springs  Florida  34689  U.S.A.
Phone: 1-908-443-1860 Fax: n/a


Company News
Matinas BioPharma (MTNB) Reports 2017 Second Quarter Financial Results And Reaffirms Clinical And Regulatory Strategy To Advance MAT2203 And MAT2501 8/8/2017 1:01:51 PM
Matinas BioPharma (MTNB) To Host Quarterly Update Conference Call 8/1/2017 1:35:54 PM
Matinas BioPharma (MTNB) Tanks As Lead Drug Fails To Match Standard-Of-Care Treatment In Phase II Infection Trial 6/26/2017 6:39:17 AM
Matinas BioPharma Announces Interim Data From NIH-Conducted Phase IIa Clinical Study Of Orally-Administered MAT2203 For The Treatment Of Chronic Refractory Mucocutaneous Candidiasis 6/5/2017 12:44:35 PM
Matinas BioPharma Reports 2017 First Quarter Financial Results And Provides Corporate Update 5/16/2017 11:10:22 AM
Matinas BioPharma Presents Positive Preclinical Data Of Orally Available DNA Vaccines At The 27th Annual European Congress Of Clinical Microbiology And Infectious Diseases 4/24/2017 11:02:36 AM
Matinas BioPharma Appoints Dominick Dipaolo As Senior Vice President Of Quality And Regulatory Compliance 4/18/2017 11:15:23 AM
Matinas BioPharma Appoints Eric J. Ende, M.B.A, M.D. To Its Board Of Directors 3/30/2017 11:17:28 AM
Matinas BioPharma To Host Fiscal Year 2016 Update Conference Call 3/29/2017 11:10:47 AM
Matinas BioPharma To Ring NYSE Closing Bell On March 29th, 2017 3/28/2017 11:25:00 AM